Risk factors for atherosclerosis in systemic autoimmune diseases

被引:0
|
作者
Silvarino, Ricardo [1 ]
Inoue Sato, Emilia [2 ]
机构
[1] Univ Republica, Hosp Clin, Fac Med, Dept Clin Med, Montevideo, Uruguay
[2] Univ Fed Sao Paulo, Escola Paulista Med, Sao Paulo, SP, Brazil
来源
REVISTA MEDICA DEL URUGUAY | 2008年 / 24卷 / 02期
关键词
AUTOIMMUNE DISEASES - complications; LUPUS ERYTHEMATOSUS; SYSTEMIC; -; complications; ARTHRITIS; RHEUMATOID; ATHEROSCLEROSIS; RISK FACTORS;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Patients with systemic autoimmune diseases have an increased risk to develop atherosclerosis. This is due to the presence of traditional cardiovascular risk factors - dyslipidemia, high blood pressure, diabetes, smoking, obesity, sedentary lifestyle- and non-traditional ones - the disease itself, hyperhomocisteinemia, corticotherapy-, which rise in a number of ways. Absolute cardiovascular risk scores were not useful to predict cardiovascular disease in this population since by considering just the traditional cardiovascular risk factors futures events are being underestimated. Systematic screening of cardiovascular risk factors and looking for subclinical atherosclerosis must be a part of the follow-up routine for this population. Upon absence of specific guidelines and understanding systematic autoimmuune diseases is a cardiovascular risk factor similar to diabetes mellitus, therapeutic objectives adopted are similar to those used for the latter. Aggressive pharmacological and non-pharmacological control of cardiovascular risk factors is the only way to reduce and is one of the leading causes of death in carriers of systemic autoimmune diseases.
引用
收藏
页码:118 / 132
页数:15
相关论文
共 50 条
  • [41] Mucormycosis in systemic autoimmune diseases
    Royer, Mathieu
    Puechal, Xavier
    JOINT BONE SPINE, 2014, 81 (04) : 303 - 307
  • [42] Infections in systemic autoimmune diseases
    Consani Fernandez, Sandra Andrea
    Diaz Cuna, Carolina Laura
    Fernandez Rey, Lucia
    Rostan Sellanes, Sofia
    Maciel Oleggini, Gabriel
    Facal Castro, Jorge Antonio
    REUMATOLOGIA CLINICA, 2021, 17 (10): : 582 - 587
  • [43] Migraine in Systemic Autoimmune Diseases
    Cavestro, Cinzia
    Ferrero, Marcella
    ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2018, 18 (02) : 124 - 134
  • [44] Systemic autoimmune diseases and the kidney
    Rovin, Brad H.
    KIDNEY INTERNATIONAL, 2020, 97 (02) : 222 - 225
  • [45] Epigenetics and autoimmune systemic diseases
    Torres Lima, Ana Maria
    Rodriguez Torres, Ana Yolanda
    REVISTA CUBANA DE REUMATOLOGIA, 2015, 17 (03): : 216 - 221
  • [46] Novel biomarkers of atherosclerosis and cardiovascular risk in autoimmune diseases: Genomics and proteomics approaches
    Lopez-Pedrera, Chary
    Barbarroja, Nuria
    Manuel Villalba, Jose
    PROTEOMICS CLINICAL APPLICATIONS, 2009, 3 (02) : 213 - 225
  • [47] Prevalence and risk factors of atherosclerosis in patients with systemic lupus erythematosus
    Stenina, OA
    Sorokin, EV
    Fomicheva, OA
    Karpov, YA
    Popkova, TV
    Reshetnyak, TM
    Nasonov, EL
    KARDIOLOGIYA, 2005, 45 (11) : 105 - 108
  • [48] Accelerated Atherosclerosis and Management of Cardiovascular Risk in Autoimmune Rheumatic Diseases: An Updated Review
    Karakasis, Paschalis
    Patoulias, Dimitrios
    Stachteas, Panagiotis
    Lefkou, Eleftheria
    Dimitroulas, Theodoros
    Fragakis, Nikolaos
    CURRENT PROBLEMS IN CARDIOLOGY, 2023, 48 (12)
  • [49] Risk factors for accelerated atherosclerosis in patients with systemic lupus erythematosus
    Marasini, B
    De Monti, M
    Ghilardi, G
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (01) : 163 - 164
  • [50] Assessment of risk factors for atherosclerosis in pediatric systemic lupus erythematosus
    Boros, C
    Bradley, T
    Cheung, M
    McCrindle, B
    Russell, J
    Silverman, E
    JOURNAL OF RHEUMATOLOGY, 2004, 31 (07) : 1429 - 1429